Carrie Cibulskis

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer

  npj Precision Oncology · 2026-04-28

• Clinical validation of a high-performance somatic exome sequencing assay: from target-enrichment strategy to variant calling

  npj Genomic Medicine · 2026-04-10

• Abstract 3992: Leveraging Ultima Genomics ppmSeq WGS-cfDNA to accurately detect clonal evolution over sequential blood biopsies

  Cancer Research · 2026-04-03

• Benchmarking of duplex sequencing approaches to reveal somatic mutation landscapes

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-12-15

• Supplemental Figure 6 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplemental Figure 3 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplemental Figure 4 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplemental Figure 2 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplemental Figure 1 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Supplemental Figure 5 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

  2025-11-25

• Distinct archetypes of clonal dynamics underlie response and resistance to diverse CLL therapies

  Blood · 2025-11-03

• Sickle cell disease is associated with early-onset clonal hematopoiesis involving DNA damage response pathway mutations

  Blood · 2025-11-03 · 4 citations

• Comprehensive benchmarking of somatic single-nucleotide variant and indel detection at ultra-low allele fractions using short- and long-read dataPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-10-14 · 1 citations

• Abstract B008: The role of circulating tumor DNA (ctDNA) in profiling hepatoblastoma tumor heterogeneity

  Cancer Research · 2025-09-25

• A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma

  Cell · 2025-07-15 · 30 citations

• Abstract 630: Directly engaging participants in rare cancer research is feasible: the osteosarcoma and leiomyosarcoma projects

  Cancer Research · 2025-04-21